Sentence examples for days until progression from inspiring English sources

Patients treated in arm A will receive docetaxel (60 mg/m) and those in arm B will receive docetaxel (60 mg/m) plus bevacizumab (15 mg/kg) on day 1 every 21 days until progression or unacceptable toxicity.

Patients in arm A will receive docetaxel at 60 mg/m and those in arm B will receive docetaxel at 60 mg/m plus bevacizumab at 15 mg/kg, with each drug administered on day 1 every 21 days until progression or unacceptable toxicity.

Treatment was repeated every 28 days until progression of disease or limiting toxicity.

Sagopilone, 16 mg m−2, was administered intravenously over 3 h every 21 days until progression or unacceptable toxicity.

The median number of days until clinical progression was 56 (range 53 112) days and median number of days until progression for those patients having s.d. is 123 (range 108 329) days.

Then, PLD, 25 mg m−2, diluted in 250 ml of 5% dextrose, was administered on day 1 by a 60 min i.v. infusion, followed by GEM, 800 mg m−2, diluted in 250 ml of 0.9% saline solution, on days 1 and 8 by a 30 min i.v. infusion; cycles were repeated every 21 days, until progression of disease, unacceptable toxicity, patients' refusal, or at pysician's discretion.

After a 4-week break, patients received adjuvant TMZ 150 to 200 mg/m2 day 1 to 5 in 28 days until tumor progression or up to at least 12 cycles [ 2].

Havrilesky et al (2003) investigated weekly carboplatin AUC 2 and paclitaxel 80 mg m−2 on day 1, 8 and 15 every 28 days until disease progression; thus not delivering dose-dense platinum, as the platinum dose intensity in this regimen is below that achieved with conventional schedules.

In both trials, patients with stable disease at day 90 after vaccination received booster vaccinations every 60 days until disease progression.

Chemotherapy was given every 21 days until disease progression or unacceptable toxicity [13].

Chemotherapy cycles consisted of temozolomide 75 mg/m/daily for 21 days every 28 days until disease progression.